COVID-19 update: April 1, 2022
Answer your patient’s important questions and locate Evusheld therapy; OPTN Policy 1.4.F expires soon; and FDA authorizes second booster
Answer your patient’s important questions and locate Evusheld therapy; OPTN Policy 1.4.F expires soon; and FDA authorizes second booster
Emergency policy had been approved for a 90-day period.
Resources for members to share with patients. New COVID-19 data element added to Center STAR files.
Patient resources to share and COVID-19 Therapeutics Locator. Reminder: reporting COVID-19-related cause of death. Site surveys in-person by end of March. NIH updates treatment guidelines.
Resources for members to share with patients. Site surveys to gradually transition to in-person visits starting in March. AST updates vaccine FAQ sheet. FDA postpones meeting on Pfizer vaccine for young children.
Resources for members to share with patients, vaccine updates from FDA and NIH treatment guidelines